Select Page

Pre-exposure prophylaxis use expands, but not fast enough

Pre-exposure prophylaxis use expands, but not fast enough

By United Nations Programme on HIV/AIDS (UNAIDS).

It has been more than a decade since the first evidence of the efficacy of daily oral pre-exposure prophylaxis (PrEP) was published.

PrEP is now a valuable additional option for people who are at higher risk of acquiring HIV, and its global uptake has continued to increase, despite the COVID-19 pandemic: country data show that approximately 845 000 people in at least 54 countries received PrEP in 2020-a 43% increase since 2019, and a 182% increase since 2018.

Much of the PrEP scale-up is still highly concentrated in a fairly small number of countries, notably the United States of America, and in eastern and southern Africa, where Kenya and South Africa accounted for 158,630 (19%) of people who received PrEP at least once during 2020 in the region.

There continue to be substantial gaps in the availability of PrEP, however: the total number of people using this prevention option in 2020 was just 28% of the target of 3 million in low- and middle-income countries, which represents only 8% of the new global 2025 target.


About The Author

News Service

News Services form an indispensable part of the newsroom toolbox. In Africa, there are several advanced providers of information, some servicing the entire continent while others are more regional, or country specific. The Namibia Economist employs a wide spectrum of local, regional, continental and international News Services.